Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 2170 - 12
Chitin deacetylases (CDAs) act on chitin polymers and low molecular weight oligomers producing chitosans and chitosan oligosaccharides. Structurally-defined,...
COLLETOTRICHUM-LINDEMUTHIANUM | METARHIZIUM-ANISOPLIAE | MUCOR-ROUXII | VERTICILLIUM-CHLAMYDOSPORIUM | EXTRACELLULAR ENZYMES | MULTIDISCIPLINARY SCIENCES | CHITOSAN | PURIFICATION | OLIGOSACCHARIDE DEACETYLASE | CRYPTOCOCCUS-NEOFORMANS | BIOLOGICAL-CONTROL | Amidohydrolases - metabolism | Catalytic Domain | Hypocreales - enzymology | Polymerization | Substrate Specificity | Acetylation | Fungal Proteins - genetics | Chitosan - metabolism | Fungal Proteins - metabolism | Nematophagous fungi | Chitin | Oligosaccharides | Molecular weight | Fungi | Pathogenicity | Deacetylation | Affinity chromatography | Substrate specificity | Inclusion bodies | Chitosan | Chitin deacetylase
COLLETOTRICHUM-LINDEMUTHIANUM | METARHIZIUM-ANISOPLIAE | MUCOR-ROUXII | VERTICILLIUM-CHLAMYDOSPORIUM | EXTRACELLULAR ENZYMES | MULTIDISCIPLINARY SCIENCES | CHITOSAN | PURIFICATION | OLIGOSACCHARIDE DEACETYLASE | CRYPTOCOCCUS-NEOFORMANS | BIOLOGICAL-CONTROL | Amidohydrolases - metabolism | Catalytic Domain | Hypocreales - enzymology | Polymerization | Substrate Specificity | Acetylation | Fungal Proteins - genetics | Chitosan - metabolism | Fungal Proteins - metabolism | Nematophagous fungi | Chitin | Oligosaccharides | Molecular weight | Fungi | Pathogenicity | Deacetylation | Affinity chromatography | Substrate specificity | Inclusion bodies | Chitosan | Chitin deacetylase
Journal Article
Food Microbiology, ISSN 0740-0020, 12/2014, Volume 44, pp. 211 - 219
The aim of this study was to extract chitosan (CHI) from UCP 050 grown in a corn steep liquor (CSL)-based medium under optimized conditions and to assess the...
Post-harvest decay | Chitosan | Edible coating | Mucor | PHYSICOCHEMICAL CHARACTERISTICS | ASPERGILLUS-NIGER | L. FRUIT | ESSENTIAL OILS | FOOD SCIENCE & TECHNOLOGY | PHYSIOLOGICAL-RESPONSES | MICROBIOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GROWTH | CHITIN | LIFE | Aspergillus niger - growth & development | Vitis - growth & development | Rhizopus - growth & development | Vitis - chemistry | Food Preservation - methods | Food Storage | Vitis - microbiology | Mucor - metabolism | Rhizopus - drug effects | Mucor - growth & development | Mucor - chemistry | Chitosan - pharmacology | Aspergillus niger - drug effects | Chitosan - metabolism | Microbiology | Grapes | Food
Post-harvest decay | Chitosan | Edible coating | Mucor | PHYSICOCHEMICAL CHARACTERISTICS | ASPERGILLUS-NIGER | L. FRUIT | ESSENTIAL OILS | FOOD SCIENCE & TECHNOLOGY | PHYSIOLOGICAL-RESPONSES | MICROBIOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GROWTH | CHITIN | LIFE | Aspergillus niger - growth & development | Vitis - growth & development | Rhizopus - growth & development | Vitis - chemistry | Food Preservation - methods | Food Storage | Vitis - microbiology | Mucor - metabolism | Rhizopus - drug effects | Mucor - growth & development | Mucor - chemistry | Chitosan - pharmacology | Aspergillus niger - drug effects | Chitosan - metabolism | Microbiology | Grapes | Food
Journal Article
Frontiers in Microbiology, ISSN 1664-302X, 06/2017, Volume 8
Valsa mali (V. mali) is the causative agent of apple tree Valsa canker, which heavily damages the production of apples in China. However, the biological roles...
Valsa mali | Dicer | Pathogenesis | Small RNA | RNAi mechanism | DOUBLE-STRANDED-RNA | FUNGUS MUCOR-CIRCINELLOIDES | MICRORNA-LIKE RNAS | INTERFERENCE MACHINERY | MICROBIOLOGY | small RNA | TIME QUANTITATIVE PCR | FILAMENTOUS FUNGI | GENOME | pathogenesis | MAGNAPORTHE-ORYZAE | PROTEINS | NEUROSPORA-CRASSA
Valsa mali | Dicer | Pathogenesis | Small RNA | RNAi mechanism | DOUBLE-STRANDED-RNA | FUNGUS MUCOR-CIRCINELLOIDES | MICRORNA-LIKE RNAS | INTERFERENCE MACHINERY | MICROBIOLOGY | small RNA | TIME QUANTITATIVE PCR | FILAMENTOUS FUNGI | GENOME | pathogenesis | MAGNAPORTHE-ORYZAE | PROTEINS | NEUROSPORA-CRASSA
Journal Article
Clinical Microbiology Reviews, ISSN 0893-8512, 10/1996, Volume 9, Issue 4, pp. 469 - 488
Services CMR Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon...
BRONCHOALVEOLAR MACROPHAGE DEFENSE | TUMOR-NECROSIS-FACTOR | CRYPTOCOCCAL CAPSULAR POLYSACCHARIDE | NEOFORMANS SEROTYPE-A | INVASIVE PULMONARY ASPERGILLOSIS | CHRONIC GRANULOMATOUS-DISEASE | ESTRADIOL-BINDING PROTEINS | MICROBIOLOGY | GENETICALLY RELATED STRAINS | HUMAN-IMMUNODEFICIENCY-VIRUS | BLASTOMYCES-DERMATITIDIS YEASTS | Toxins, Biological - adverse effects | Coccidioides - pathogenicity | Humans | Virulence | Antigens, Fungal - adverse effects | Mycoses - microbiology | Cell Wall - chemistry | Mucor - pathogenicity | Cryptococcus neoformans - pathogenicity | Histoplasma - pathogenicity | Aspergillus - pathogenicity | Blastomyces - pathogenicity | Fungal Proteins - adverse effects | Paracoccidioides - pathogenicity | Sporothrix - pathogenicity
BRONCHOALVEOLAR MACROPHAGE DEFENSE | TUMOR-NECROSIS-FACTOR | CRYPTOCOCCAL CAPSULAR POLYSACCHARIDE | NEOFORMANS SEROTYPE-A | INVASIVE PULMONARY ASPERGILLOSIS | CHRONIC GRANULOMATOUS-DISEASE | ESTRADIOL-BINDING PROTEINS | MICROBIOLOGY | GENETICALLY RELATED STRAINS | HUMAN-IMMUNODEFICIENCY-VIRUS | BLASTOMYCES-DERMATITIDIS YEASTS | Toxins, Biological - adverse effects | Coccidioides - pathogenicity | Humans | Virulence | Antigens, Fungal - adverse effects | Mycoses - microbiology | Cell Wall - chemistry | Mucor - pathogenicity | Cryptococcus neoformans - pathogenicity | Histoplasma - pathogenicity | Aspergillus - pathogenicity | Blastomyces - pathogenicity | Fungal Proteins - adverse effects | Paracoccidioides - pathogenicity | Sporothrix - pathogenicity
Journal Article
Medical Mycology, ISSN 1369-3786, 01/2013, Volume 51, Issue 1, pp. 72 - 82
Members of the order Mucorales are emerging invasive molds that cause infections in immunocompromised patients. However, little is known about the relation...
Rabbits | Pulmonary mucormycosis | Cunninghamella bertholletiae | Virulence | DIAGNOSIS | INFECTIOUS DISEASES | ZYGOMYCOSIS | rabbits | TISSUE | QUANTITATIVE PCR | PNEUMONIA | pulmonary mucormycosis | ASPERGILLOSIS | virulence | NOSOCOMIAL FUNGAL-INFECTIONS | GRANULOCYTOPENIA | VETERINARY SCIENCES | PATIENT | MYCOLOGY | EPIDEMIOLOGY | Mucorales - isolation & purification | DNA, Fungal - genetics | Species Specificity | Humans | Sporangia | Mucor - metabolism | Mucorales - metabolism | Mucorales - pathogenicity | DNA, Fungal - chemistry | Mucorales - genetics | DNA, Ribosomal - chemistry | Lung Diseases, Fungal - microbiology | Cunninghamella - genetics | Cunninghamella - metabolism | Lung Diseases, Fungal - pathology | Mucormycosis - pathology | Female | DNA, Fungal - blood | DNA, Ribosomal - blood | Rhizopus - metabolism | Rhizopus - pathogenicity | DNA, Ribosomal - genetics | Cunninghamella - pathogenicity | Mucor - genetics | Rhizopus - genetics | Cunninghamella - isolation & purification | Mucor - pathogenicity | Immunosuppression | Animals | Mucor - isolation & purification | Mucormycosis - microbiology | Spores, Fungal | Hyphae | Survival Analysis | Biomarkers | Rhizopus - isolation & purification
Rabbits | Pulmonary mucormycosis | Cunninghamella bertholletiae | Virulence | DIAGNOSIS | INFECTIOUS DISEASES | ZYGOMYCOSIS | rabbits | TISSUE | QUANTITATIVE PCR | PNEUMONIA | pulmonary mucormycosis | ASPERGILLOSIS | virulence | NOSOCOMIAL FUNGAL-INFECTIONS | GRANULOCYTOPENIA | VETERINARY SCIENCES | PATIENT | MYCOLOGY | EPIDEMIOLOGY | Mucorales - isolation & purification | DNA, Fungal - genetics | Species Specificity | Humans | Sporangia | Mucor - metabolism | Mucorales - metabolism | Mucorales - pathogenicity | DNA, Fungal - chemistry | Mucorales - genetics | DNA, Ribosomal - chemistry | Lung Diseases, Fungal - microbiology | Cunninghamella - genetics | Cunninghamella - metabolism | Lung Diseases, Fungal - pathology | Mucormycosis - pathology | Female | DNA, Fungal - blood | DNA, Ribosomal - blood | Rhizopus - metabolism | Rhizopus - pathogenicity | DNA, Ribosomal - genetics | Cunninghamella - pathogenicity | Mucor - genetics | Rhizopus - genetics | Cunninghamella - isolation & purification | Mucor - pathogenicity | Immunosuppression | Animals | Mucor - isolation & purification | Mucormycosis - microbiology | Spores, Fungal | Hyphae | Survival Analysis | Biomarkers | Rhizopus - isolation & purification
Journal Article
Seminars in Respiratory and Critical Care Medicine, ISSN 1069-3424, 12/2011, Volume 32, Issue 6, pp. 693 - 702
ABSTRACT Mucormycosis (formerly zygomycosis) is a life-threatening opportunistic mycosis that infects a broad range of hosts with qualitative or quantitative...
Mucormycosis | zygomycosis | immunocompromised | hematologic malignancy | Mucor | Rhizopus | RHIZOPUS-ORYZAE | LIPID COMPLEX | RECIPIENTS RECEIVING VORICONAZOLE | DISSEMINATED ZYGOMYCOSIS | INVASIVE FUNGAL-INFECTIONS | LIPOSOMAL AMPHOTERICIN-B | IN-VITRO | ORGAN TRANSPLANT RECIPIENTS | RESPIRATORY SYSTEM | CARE CANCER CENTER | SALVAGE THERAPY | CRITICAL CARE MEDICINE | Lung Diseases, Fungal - diagnosis | Mucormycosis - epidemiology | Mucormycosis - physiopathology | Lung Diseases, Fungal - immunology | Lung Diseases, Fungal - epidemiology | Mucormycosis - diagnosis | Humans | Mucorales - immunology | Mucorales - pathogenicity | Mucormycosis - therapy | Rhizomucor - immunology | Lung Diseases, Fungal - therapy | Antifungal Agents - therapeutic use | Debridement | Mucor - pathogenicity | Mucormycosis - immunology | Mucor - immunology | Rhizomucor - pathogenicity | Rhizopus - immunology | Immunocompromised Host | Lung Diseases, Fungal - physiopathology | Rhizopus - pathogenicity | Hyperbaric Oxygenation | Opportunistic Infections - complications
Mucormycosis | zygomycosis | immunocompromised | hematologic malignancy | Mucor | Rhizopus | RHIZOPUS-ORYZAE | LIPID COMPLEX | RECIPIENTS RECEIVING VORICONAZOLE | DISSEMINATED ZYGOMYCOSIS | INVASIVE FUNGAL-INFECTIONS | LIPOSOMAL AMPHOTERICIN-B | IN-VITRO | ORGAN TRANSPLANT RECIPIENTS | RESPIRATORY SYSTEM | CARE CANCER CENTER | SALVAGE THERAPY | CRITICAL CARE MEDICINE | Lung Diseases, Fungal - diagnosis | Mucormycosis - epidemiology | Mucormycosis - physiopathology | Lung Diseases, Fungal - immunology | Lung Diseases, Fungal - epidemiology | Mucormycosis - diagnosis | Humans | Mucorales - immunology | Mucorales - pathogenicity | Mucormycosis - therapy | Rhizomucor - immunology | Lung Diseases, Fungal - therapy | Antifungal Agents - therapeutic use | Debridement | Mucor - pathogenicity | Mucormycosis - immunology | Mucor - immunology | Rhizomucor - pathogenicity | Rhizopus - immunology | Immunocompromised Host | Lung Diseases, Fungal - physiopathology | Rhizopus - pathogenicity | Hyperbaric Oxygenation | Opportunistic Infections - complications
Journal Article
PLoS Pathogens, ISSN 1553-7366, 09/2013, Volume 9, Issue 9, p. e1003625
Many pathogenic fungi are dimorphic and switch between yeast and filamentous states. This switch alters host-microbe interactions and is critical for...
PROTEIN-KINASE-A | IN-VITRO INTERACTION | REGULATORY SUBUNIT | YEAST DIMORPHISM | POLARIZED GROWTH | MICROBIOLOGY | TRANSPLANT RECIPIENTS | ROUXII SPORANGIOSPORES | CANDIDA-ALBICANS | VIROLOGY | CRYPTOCOCCUS-NEOFORMANS | HYPHAL GROWTH | PARASITOLOGY | Protein Structure, Tertiary | Cell Line | Hyphae - genetics | Mucor - enzymology | Mucor - genetics | Virulence Factors - genetics | Humans | Mucormycosis - metabolism | Fungal Proteins - genetics | Mucor - pathogenicity | Calcineurin - genetics | Hyphae - pathogenicity | Mucormycosis - genetics | Mucormycosis - pathology | Tacrolimus - pharmacology | Virulence Factors - metabolism | Hyphae - enzymology | Immunosuppressive Agents - pharmacology | Calcineurin - metabolism | Fungal Proteins - metabolism | Physiological aspects | Zygomycetes | Dimorphism (Biology) | Research | Health aspects | Calcineurin | Fungi | Yeast | Microbiology | Mortality | Ribosomal DNA | Fungal infections | Diabetes | Kinases
PROTEIN-KINASE-A | IN-VITRO INTERACTION | REGULATORY SUBUNIT | YEAST DIMORPHISM | POLARIZED GROWTH | MICROBIOLOGY | TRANSPLANT RECIPIENTS | ROUXII SPORANGIOSPORES | CANDIDA-ALBICANS | VIROLOGY | CRYPTOCOCCUS-NEOFORMANS | HYPHAL GROWTH | PARASITOLOGY | Protein Structure, Tertiary | Cell Line | Hyphae - genetics | Mucor - enzymology | Mucor - genetics | Virulence Factors - genetics | Humans | Mucormycosis - metabolism | Fungal Proteins - genetics | Mucor - pathogenicity | Calcineurin - genetics | Hyphae - pathogenicity | Mucormycosis - genetics | Mucormycosis - pathology | Tacrolimus - pharmacology | Virulence Factors - metabolism | Hyphae - enzymology | Immunosuppressive Agents - pharmacology | Calcineurin - metabolism | Fungal Proteins - metabolism | Physiological aspects | Zygomycetes | Dimorphism (Biology) | Research | Health aspects | Calcineurin | Fungi | Yeast | Microbiology | Mortality | Ribosomal DNA | Fungal infections | Diabetes | Kinases
Journal Article
Zeitschrift für Naturforschung C, ISSN 0939-5075, 01/2016, Volume 71, Issue 1, pp. 15 - 19
The new cyclic heptapeptide unguisin F ( ) and the known congener unguisin E ( ), were obtained from the endophytic fungus , isolated from the medicinal plant...
peptide | Moringa stenopetala | Mucor irregularis | SEEDS | EMERICELLA-UNGUIS | OLEIFERA | NATURAL-PRODUCTS | BIOCHEMISTRY & MOLECULAR BIOLOGY | PLANTS | SOIL | PHARMACOLOGY & PHARMACY | MORINGA-STENOPETALA | Peptides, Cyclic - isolation & purification | Fungi - drug effects | Magnetic Resonance Spectroscopy | Humans | Bacteria - drug effects | Peptides, Cyclic - pharmacology | Antifungal Agents - chemistry | Anti-Bacterial Agents - isolation & purification | Peptides, Cyclic - chemistry | Antifungal Agents - isolation & purification | Mucor - pathogenicity | Mucor - chemistry | Mucormycosis - microbiology | Anti-Bacterial Agents - chemistry | Mucormycosis - pathology | Fungi - pathogenicity | Bacteria - pathogenicity | Molecular Structure | Mucormycosis - drug therapy | Fungi | Amino acids | Nuclear magnetic resonance spectroscopy | Peptides
peptide | Moringa stenopetala | Mucor irregularis | SEEDS | EMERICELLA-UNGUIS | OLEIFERA | NATURAL-PRODUCTS | BIOCHEMISTRY & MOLECULAR BIOLOGY | PLANTS | SOIL | PHARMACOLOGY & PHARMACY | MORINGA-STENOPETALA | Peptides, Cyclic - isolation & purification | Fungi - drug effects | Magnetic Resonance Spectroscopy | Humans | Bacteria - drug effects | Peptides, Cyclic - pharmacology | Antifungal Agents - chemistry | Anti-Bacterial Agents - isolation & purification | Peptides, Cyclic - chemistry | Antifungal Agents - isolation & purification | Mucor - pathogenicity | Mucor - chemistry | Mucormycosis - microbiology | Anti-Bacterial Agents - chemistry | Mucormycosis - pathology | Fungi - pathogenicity | Bacteria - pathogenicity | Molecular Structure | Mucormycosis - drug therapy | Fungi | Amino acids | Nuclear magnetic resonance spectroscopy | Peptides
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 5/2009, Volume 199, Issue 9, pp. 1399 - 1406
Background, Breakthrough zygomycosis is increasingly observed among patients at high risk for fungal infection who are receiving voriconazole, reflecting...
Fungi | Infectious diseases | Virulence | Drosophila | Infections | Mice | Fungal infections | Survival rates | Fungal spores | Zygomycosis | Inoculum | ASPERGILLOSIS | INFECTIOUS DISEASES | THERAPY | DROSOPHILA-MELANOGASTER | CARE CANCER CENTER | RECIPIENTS RECEIVING VORICONAZOLE | HOST | MICROBIOLOGY | ANTIFUNGAL DRUG EFFICACY | IMMUNOLOGY | BREAKTHROUGH FUNGAL-INFECTIONS | Antifungal Agents - pharmacology | Aspergillus fumigatus - drug effects | Drosophila - drug effects | Virulence - drug effects | Fungi - drug effects | Humans | Fungi - isolation & purification | Zygomycosis - pathology | Pyrimidines - pharmacology | Antifungal Agents - therapeutic use | Zygomycosis - physiopathology | Itraconazole - therapeutic use | Triazoles - pharmacology | Mucor - pathogenicity | Animals | Aspergillus fumigatus - isolation & purification | Voriconazole | Amphotericin B - therapeutic use | Rhizopus - pathogenicity | Zygomycosis - drug therapy | Disease Models, Animal | Zygomycetes | Mucormycosis | Usage | Animal models in research | Physiological aspects | Research | Risk factors
Fungi | Infectious diseases | Virulence | Drosophila | Infections | Mice | Fungal infections | Survival rates | Fungal spores | Zygomycosis | Inoculum | ASPERGILLOSIS | INFECTIOUS DISEASES | THERAPY | DROSOPHILA-MELANOGASTER | CARE CANCER CENTER | RECIPIENTS RECEIVING VORICONAZOLE | HOST | MICROBIOLOGY | ANTIFUNGAL DRUG EFFICACY | IMMUNOLOGY | BREAKTHROUGH FUNGAL-INFECTIONS | Antifungal Agents - pharmacology | Aspergillus fumigatus - drug effects | Drosophila - drug effects | Virulence - drug effects | Fungi - drug effects | Humans | Fungi - isolation & purification | Zygomycosis - pathology | Pyrimidines - pharmacology | Antifungal Agents - therapeutic use | Zygomycosis - physiopathology | Itraconazole - therapeutic use | Triazoles - pharmacology | Mucor - pathogenicity | Animals | Aspergillus fumigatus - isolation & purification | Voriconazole | Amphotericin B - therapeutic use | Rhizopus - pathogenicity | Zygomycosis - drug therapy | Disease Models, Animal | Zygomycetes | Mucormycosis | Usage | Animal models in research | Physiological aspects | Research | Risk factors
Journal Article
Enzyme and Microbial Technology, ISSN 0141-0229, 05/2018, Volume 112, pp. 35 - 42
The use of cell wall degrading enzymes of is a promising alternative for improving food storage. The aspartic protease P6281 secreted by the fungus plays an...
Trichoderma harzianum | Antifungal activity | Recombinant aspartic protease | Biocontrol | IDENTIFICATION | IN-VITRO | GENE | CLONING | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | PICHIA-PASTORIS | SERINE-PROTEASE | CECT-2413 | HETEROLOGOUS EXPRESSION | PROTEINS | EPIDEMIOLOGY | Plant Diseases - microbiology | Trichoderma - enzymology | Food Microbiology | Botrytis - pathogenicity | Food Contamination - prevention & control | Cell Wall - drug effects | Aspartic Acid Proteases - genetics | Fungi - pathogenicity | Genes, Fungal | Cell Wall - ultrastructure | Fungi - growth & development | Botrytis - growth & development | Antifungal Agents - pharmacology | Recombinant Proteins - metabolism | Fungi - drug effects | Food Storage | Recombinant Proteins - genetics | Trichoderma - genetics | Fungal Proteins - genetics | Recombinant Proteins - pharmacology | Plant Diseases - prevention & control | Aspartic Acid Proteases - metabolism | Botrytis - drug effects | Aspartic Acid Proteases - pharmacology | Fungal Proteins - pharmacology | Fungal Proteins - metabolism
Trichoderma harzianum | Antifungal activity | Recombinant aspartic protease | Biocontrol | IDENTIFICATION | IN-VITRO | GENE | CLONING | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | PICHIA-PASTORIS | SERINE-PROTEASE | CECT-2413 | HETEROLOGOUS EXPRESSION | PROTEINS | EPIDEMIOLOGY | Plant Diseases - microbiology | Trichoderma - enzymology | Food Microbiology | Botrytis - pathogenicity | Food Contamination - prevention & control | Cell Wall - drug effects | Aspartic Acid Proteases - genetics | Fungi - pathogenicity | Genes, Fungal | Cell Wall - ultrastructure | Fungi - growth & development | Botrytis - growth & development | Antifungal Agents - pharmacology | Recombinant Proteins - metabolism | Fungi - drug effects | Food Storage | Recombinant Proteins - genetics | Trichoderma - genetics | Fungal Proteins - genetics | Recombinant Proteins - pharmacology | Plant Diseases - prevention & control | Aspartic Acid Proteases - metabolism | Botrytis - drug effects | Aspartic Acid Proteases - pharmacology | Fungal Proteins - pharmacology | Fungal Proteins - metabolism
Journal Article
International Journal of Biological Macromolecules, ISSN 0141-8130, 2010, Volume 47, Issue 1, pp. 10 - 14
Four fungal chitosan types (CTS) were prepared from DSM 1191 and examined for their physico-chemical characteristics. The antimicrobial activity of chitosan...
Pathogenic bacteria | Natural biocides | Microbial chitosan | BACTERIA | ANTIBACTERIAL ACTIVITY | MEMBRANE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ESCHERICHIA-COLI | Anti-Infective Agents - isolation & purification | Chitosan - chemistry | Gram-Positive Bacteria - pathogenicity | Mucor - chemistry | Anti-Infective Agents - chemistry | Anti-Infective Agents - pharmacology | Gram-Negative Bacteria - growth & development | Gram-Negative Bacteria - pathogenicity | Chitosan - pharmacology | Gram-Positive Bacteria - growth & development | Chitosan - isolation & purification | Antimicrobial activity
Pathogenic bacteria | Natural biocides | Microbial chitosan | BACTERIA | ANTIBACTERIAL ACTIVITY | MEMBRANE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ESCHERICHIA-COLI | Anti-Infective Agents - isolation & purification | Chitosan - chemistry | Gram-Positive Bacteria - pathogenicity | Mucor - chemistry | Anti-Infective Agents - chemistry | Anti-Infective Agents - pharmacology | Gram-Negative Bacteria - growth & development | Gram-Negative Bacteria - pathogenicity | Chitosan - pharmacology | Gram-Positive Bacteria - growth & development | Chitosan - isolation & purification | Antimicrobial activity
Journal Article
Medical Mycology, ISSN 1369-3786, 3/2005, Volume 43, Issue 2, pp. 127 - 132
Platypuses (Ornithorhynchus anatinus) in the north of the island state of Tasmania, Australia, suffer from a serious disease called ulcerative mycosis, which...
cane toad | pathogenicity | platypus | Mucor amphibiorum | Pathogenicity | Cane toad | Platypus | ORNITHORHYNCHUS-ANATINUS | AUSTRALIA | VETERINARY SCIENCES | MYCOLOGY | PIRIFORMIS | Granuloma - microbiology | Granuloma - veterinary | Mucormycosis - veterinary | Bufo marinus - microbiology | Mucor - pathogenicity | Animals | Mucor - isolation & purification | Anura - microbiology | Mucormycosis - microbiology | Mucormycosis - pathology | Australia | Platypus - microbiology | Disease Models, Animal
cane toad | pathogenicity | platypus | Mucor amphibiorum | Pathogenicity | Cane toad | Platypus | ORNITHORHYNCHUS-ANATINUS | AUSTRALIA | VETERINARY SCIENCES | MYCOLOGY | PIRIFORMIS | Granuloma - microbiology | Granuloma - veterinary | Mucormycosis - veterinary | Bufo marinus - microbiology | Mucor - pathogenicity | Animals | Mucor - isolation & purification | Anura - microbiology | Mucormycosis - microbiology | Mucormycosis - pathology | Australia | Platypus - microbiology | Disease Models, Animal
Journal Article
Platelets, ISSN 0953-7104, 02/2019, Volume 30, Issue 2, pp. 256 - 263
Thrombosis is a hallmark of the fatal fungal infection mucormycosis. Yet, the platelet activation pathway in response to mucormycetes is unknown. In this study...
mucormycetes | thrombosis | mucormycosis | FcγRIIA | platelets | Mucor circinelloides | Mucor - pathogenicity | Receptors, IgG - genetics | Platelet Aggregation - immunology | Humans | Thrombosis - immunology
mucormycetes | thrombosis | mucormycosis | FcγRIIA | platelets | Mucor circinelloides | Mucor - pathogenicity | Receptors, IgG - genetics | Platelet Aggregation - immunology | Humans | Thrombosis - immunology
Journal Article
Methods in Molecular Biology, ISSN 1064-3745, 2017, Volume 1508, pp. 17 - 65
Invasive fungal infections (IFI) are an emerging problem worldwide with invasive candidiasis and candidemia responsible for the majority of cases. This is...
Aspergillus | Dimorphic fungi | Histoplasma | Candida | Paracoccidioides | Cryptococcus | Fusarium | Dermatophytes | Pneumocystis | Mucor | Scedosporium | Antifungal Agents - pharmacology | Animals | Disease Susceptibility | Invasive Fungal Infections - epidemiology | Invasive Fungal Infections - therapy | Humans | Fungi - pathogenicity | Drug Resistance, Fungal | Invasive Fungal Infections - microbiology | Antifungal Agents - therapeutic use | Cohort Studies | Incidence
Aspergillus | Dimorphic fungi | Histoplasma | Candida | Paracoccidioides | Cryptococcus | Fusarium | Dermatophytes | Pneumocystis | Mucor | Scedosporium | Antifungal Agents - pharmacology | Animals | Disease Susceptibility | Invasive Fungal Infections - epidemiology | Invasive Fungal Infections - therapy | Humans | Fungi - pathogenicity | Drug Resistance, Fungal | Invasive Fungal Infections - microbiology | Antifungal Agents - therapeutic use | Cohort Studies | Incidence
Journal Article
Cytopathology, ISSN 0956-5507, 12/2016, Volume 27, Issue 6, pp. 491 - 494
This case report reviews fungal elements found in cervico‐vaginal samples and the use of molecular techniques in their identification and evaluation of...
SMEAR | PATHOLOGY | BLASTOMYCOSIS | PARACOCCIDIOIDES-BRASILIENSIS | CELL BIOLOGY | Reproductive Tract Infections - microbiology | Mucor - genetics | Reproductive Tract Infections - pathology | Humans | Reproductive Tract Infections - epidemiology | Mucor - pathogenicity | Cytodiagnosis | Mucor - isolation & purification | Reproductive Tract Infections - diagnosis | Adult | Female | Paracoccidioides - pathogenicity | High-Throughput Nucleotide Sequencing | Vagina - microbiology | Vagina - pathology | Epidemiology
SMEAR | PATHOLOGY | BLASTOMYCOSIS | PARACOCCIDIOIDES-BRASILIENSIS | CELL BIOLOGY | Reproductive Tract Infections - microbiology | Mucor - genetics | Reproductive Tract Infections - pathology | Humans | Reproductive Tract Infections - epidemiology | Mucor - pathogenicity | Cytodiagnosis | Mucor - isolation & purification | Reproductive Tract Infections - diagnosis | Adult | Female | Paracoccidioides - pathogenicity | High-Throughput Nucleotide Sequencing | Vagina - microbiology | Vagina - pathology | Epidemiology
Journal Article
Scientia Horticulturae, ISSN 0304-4238, 10/2019, Volume 256, p. 108589
spp. is the main pathogen responsible for postharvest losses of stone fruit. Several studies have examined the conditions for spp. infection in the field, but...
Brown rot | Monilinia spp | Nectarine | Cold storing | Peach | Postharvest | Water dumping | WETNESS DURATION | PEACH ORCHARDS | BROWN-ROT | GERMINATION | MUCOR-PIRIFORMIS | AFFECTING LATENT INFECTION | HORTICULTURE | PATHOGENICITY | TEMPERATURE | LAXA | EBRO VALLEY
Brown rot | Monilinia spp | Nectarine | Cold storing | Peach | Postharvest | Water dumping | WETNESS DURATION | PEACH ORCHARDS | BROWN-ROT | GERMINATION | MUCOR-PIRIFORMIS | AFFECTING LATENT INFECTION | HORTICULTURE | PATHOGENICITY | TEMPERATURE | LAXA | EBRO VALLEY
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 1/2012, Volume 54, Issue suppl_1, pp. S44 - S54
Mucormycosis is a severe emerging invasive fungal infection that occurs as a consequence of environmental exposure. We exhaustively reviewed all the cases of...
Mucormycosis | Mucorales | Rhizopus | Diabetes mellitus | Predisposing factors | Infections | Transplantation | Fungal infections | Mucor | Zygomycosis | INFECTIOUS DISEASES | ABSIDIA-CORYMBIFERA INFECTION | MICROBIOLOGY | IMMUNOLOGY | PRIMARY CUTANEOUS MUCORMYCOSIS | SURVEILLANCE NETWORK TRANSNET | ORGAN TRANSPLANT RECIPIENTS | NEONATAL GASTROINTESTINAL MUCORMYCOSIS | BONE-MARROW TRANSPLANTATION | AMBULATORY PERITONEAL-DIALYSIS | OF-THE-LITERATURE | ZYGOMYCOTIC NECROTIZING CELLULITIS | WOODEN TONGUE DEPRESSORS | Diabetes Mellitus - pathology | Lung - microbiology | Humans | Male | Equipment Contamination | Gastrointestinal Tract - pathology | Antifungal Agents - therapeutic use | Cross Infection - transmission | Cross Infection - pathology | Disease Outbreaks | Mucormycosis - pathology | Female | Dermatomycoses - pathology | Mucormycosis - drug therapy | Child | Rhizopus - pathogenicity | Lung - pathology | Mucormycosis - transmission | Risk Factors | Gastrointestinal Tract - microbiology | Treatment Outcome | Bandages - microbiology | Cross Infection - drug therapy | Diabetes Mellitus - microbiology | Mucormycosis - microbiology | Cross Infection - microbiology | Organ Transplantation - adverse effects | Dermatomycoses - microbiology
Mucormycosis | Mucorales | Rhizopus | Diabetes mellitus | Predisposing factors | Infections | Transplantation | Fungal infections | Mucor | Zygomycosis | INFECTIOUS DISEASES | ABSIDIA-CORYMBIFERA INFECTION | MICROBIOLOGY | IMMUNOLOGY | PRIMARY CUTANEOUS MUCORMYCOSIS | SURVEILLANCE NETWORK TRANSNET | ORGAN TRANSPLANT RECIPIENTS | NEONATAL GASTROINTESTINAL MUCORMYCOSIS | BONE-MARROW TRANSPLANTATION | AMBULATORY PERITONEAL-DIALYSIS | OF-THE-LITERATURE | ZYGOMYCOTIC NECROTIZING CELLULITIS | WOODEN TONGUE DEPRESSORS | Diabetes Mellitus - pathology | Lung - microbiology | Humans | Male | Equipment Contamination | Gastrointestinal Tract - pathology | Antifungal Agents - therapeutic use | Cross Infection - transmission | Cross Infection - pathology | Disease Outbreaks | Mucormycosis - pathology | Female | Dermatomycoses - pathology | Mucormycosis - drug therapy | Child | Rhizopus - pathogenicity | Lung - pathology | Mucormycosis - transmission | Risk Factors | Gastrointestinal Tract - microbiology | Treatment Outcome | Bandages - microbiology | Cross Infection - drug therapy | Diabetes Mellitus - microbiology | Mucormycosis - microbiology | Cross Infection - microbiology | Organ Transplantation - adverse effects | Dermatomycoses - microbiology
Journal Article